Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the new Genedata Expressionist for Mass Spectrometry will be showcased at the 61st ASMS Conference on Mass Spectrometry. Compatible with data formats from all major MS vendors, Genedata Expressionist software significantly improves MS lab productivity. It provides an enterprise-level, integrated, and automated data analysis platform, which covers major biopharmaceutical applications including: characterization of post-translational modifications; glycosylation studies; mass analysis of intact proteins; and host cell protein analysis. During ASMS 2013, Genedata will preview the latest version of Genedata Expressionist at the Minneapolis Convention Center (June 10-13; Booth #46) and at the Rochester Hospitality Suite at the Hilton Minneapolis Hotel (June 10-12; 8pm – 11pm).
Data Processing Time Reduced from Weeks to Hours
Genedata Expressionist for Mass Spectrometry standardizes and automates the analysis of massive mass spectrometry datasets while offering state-of-the-art algorithms for high quality results. “We have implemented Genedata Expressionist for key parts of our workflow in biotherapeutics stability assessment and have successfully removed a major data analysis bottleneck,” noted a senior scientist at Janssen R&D. “What previously took us a month of work, we do now within a day. And, Expressionist’s excellent data visualization tools help to simplify our decision-making processes.”
“We are excited and encouraged by the market adoption of Genedata Expressionist for Mass Spectrometry, which effectively addresses a data analysis bottleneck for our customers,” said Dr. Othmar Pfannes, CEO of Genedata. “We are committed to advancing Genedata Expressionist as the vendor-agnostic platform of choice for MS data analysis and helping to make key processes in biopharmaceutical R&D as efficient as possible.”
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. www.genedata.com.
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.